Literature DB >> 3605671

Midazolam as an induction agent in children: a pharmacokinetic and clinical study.

M Salonen, J Kanto, E Iisalo, J J Himberg.   

Abstract

The pharmacokinetics of midazolam was studied in 21 children undergoing elective surgery at five different dose levels for induction of general anesthesia and were compared with a control group (n = 6) given thiopental, 5 mg/kg. The clearance of midazolam was found to be dose-related. The elimination half-life varied from 0.79 to 2.83 hr, which is shorter than in adult patients. Even a dose of 0.6 mg/kg midazolam was found to be unreliable as an agent for induction of anesthesia. Compared with thiopental 5 mg/kg, significantly longer times of onset to closing of the eyes (P less than 0.01) and the disappearance of eyelid reflex (P less than 0.01) were seen with midazolam.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3605671

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

Review 1.  New drugs and new understandings of paediatric pharmacology.

Authors:  D J Steward
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 2.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 3.  Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Authors:  R E Kauffman; G L Kearns
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit.

Authors:  S Hartwig; B Roth; M Theisohn
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

5.  An approach for dose finding of drugs in infants: sedation by midazolam studied using the continual reassessment method.

Authors:  E Fabre; S Chevret; J F Piechaud; E Rey; F Vauzelle-Kervoedan; P D'Athis; G Olive; G Pons
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 6.  Clinical pharmacology of midazolam in infants and children.

Authors:  J L Blumer
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

7.  Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

Authors:  Eva Germovsek; Charlotte I S Barker; Mike Sharland; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2016-12-02       Impact factor: 4.335

Review 8.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

Review 9.  Sedation for pediatric endoscopy.

Authors:  Myung Chul Lee
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-03-31

Review 10.  Inter-individual variation in midazolam clearance in children.

Authors:  Mohammed I Altamimi; Helen Sammons; Imti Choonara
Journal:  Arch Dis Child       Date:  2014-10-03       Impact factor: 3.791

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.